Position in LEGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,580,798
+$2,350,127 QoQ
Shares Held
227,867
-2.6% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 217 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. LEGN ranks #42 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in LEGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,580,798 | 227,867 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,230,671 | 233,868 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,933,892 | 226,950 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $9,156,592 | 280,791 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $10,187,013 | 287,039 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,133,294 | 298,653 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,754,677 | 299,775 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,170,573 | 311,319 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $13,384,304 | 302,197 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $17,238,419 | 307,335 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $18,452,091 | 306,666 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $18,542,344 | 276,051 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $19,226,511 | 278,524 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $13,083,628 | 271,332 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,197,604 | 224,311 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,774,406 | 215,059 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,434,225 | 207,895 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $6,562,386 | 180,583 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,915,525 | 148,370 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,338 | 2,479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $101,762 | 2,479 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $95,591 | 3,294 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $92,759 | 3,294 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||